Peroxisome proliferator-activated receptor gamma and metabolic disease
- PMID: 11395411
- DOI: 10.1146/annurev.biochem.70.1.341
Peroxisome proliferator-activated receptor gamma and metabolic disease
Abstract
The nuclear peroxisome proliferator-activated receptor gamma (PPAR gamma) is a transcription factor that is activated by polyunsaturated fatty acids and their metabolites and is essential for fat cell formation. Although obesity is a strong risk factor for type 2 diabetes mellitus and other metabolic diseases, potent PPAR gamma activators such as the glitazone drugs lower glucose and lipid levels in patients with type 2 diabetes and also have antiatherosclerotic and antihypertensive effects. We review recent studies providing insight into the paradoxical relationship between PPAR gamma and metabolic disease. We also review recent advances in understanding the structural basis for PPAR gamma activation by ligands. The unusual ligand-binding properties of PPAR gamma suggest that it will be possible to discover new chemical classes of receptor "modulators" with distinct pharmacological activities for the treatment of type 2 diabetes and other metabolic diseases.
Similar articles
-
Peroxisome proliferator-activated receptor gamma in diabetes and metabolism.Trends Pharmacol Sci. 2004 Jun;25(6):331-6. doi: 10.1016/j.tips.2004.03.012. Trends Pharmacol Sci. 2004. PMID: 15165749 Review.
-
Peroxisome proliferator-activated receptors as molecular targets for drug therapy.J Assoc Physicians India. 2003 Jan;51:49-52. J Assoc Physicians India. 2003. PMID: 12693455
-
PPAR alpha, fibrates, lipid metabolism and inflammation.Arch Mal Coeur Vaiss. 2004 Jun;97(6):665-72. Arch Mal Coeur Vaiss. 2004. PMID: 15283041 Review.
-
Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.Circ Res. 2004 May 14;94(9):1168-78. doi: 10.1161/01.RES.0000127122.22685.0A. Circ Res. 2004. PMID: 15142970 Review.
-
[Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism].Ann Biol Clin (Paris). 2003 May-Jun;61(3):295-303. Ann Biol Clin (Paris). 2003. PMID: 12805006 Review. French.
Cited by
-
(+)-Rutamarin as a dual inducer of both GLUT4 translocation and expression efficiently ameliorates glucose homeostasis in insulin-resistant mice.PLoS One. 2012;7(2):e31811. doi: 10.1371/journal.pone.0031811. Epub 2012 Feb 27. PLoS One. 2012. PMID: 22384078 Free PMC article.
-
Macrophage-specific expression of human lysosomal acid lipase corrects inflammation and pathogenic phenotypes in lal-/- mice.Am J Pathol. 2006 Sep;169(3):916-26. doi: 10.2353/ajpath.2006.051327. Am J Pathol. 2006. PMID: 16936266 Free PMC article.
-
Perilipin 2 Protects against Lipotoxicity-Induced Islet Fibrosis by Inducing Islet Stellate Cell Activation Phenotype Changes.Biomed Res Int. 2022 Jul 6;2022:4581405. doi: 10.1155/2022/4581405. eCollection 2022. Biomed Res Int. 2022. PMID: 35845956 Free PMC article.
-
Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism.Genome Res. 2011 Sep;21(9):1417-25. doi: 10.1101/gr.123745.111. Epub 2011 Jun 14. Genome Res. 2011. PMID: 21673050 Free PMC article.
-
Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation.PLoS One. 2009;4(3):e4723. doi: 10.1371/journal.pone.0004723. Epub 2009 Mar 23. PLoS One. 2009. PMID: 19305508 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
